There are 70 coronavirus vaccines in development globally, with three candidates already being tested in human trials, according to the World Health Organization (WHO), as drugmakers race to find a cure for the deadly pathogen.
The furthest along in the clinical process is an experimental vaccine developed by Hong Kong-listed CanSino Biologics Inc. and the Beijing Institute of Biotechnology, which is in phase 2. The other two being tested on humans are treatments developed separately by US drugmakers Moderna and Inovio Pharmaceuticals , according to a WHO document.
Progress is occurring at unprecedented speed in developing vaccines as the infectious pathogen looks unlikely to be stamped out through containment measures alone.
The drug industry is hoping to compress the time it takes to get a vaccine to market — usually about 10 to 15 years — to within the next year.
Drugmakers, big and small, have jumped in to try to develop a vaccine, which would be the most effective way to contain the virus. Pharmaceutical giants like Pfizer Inc. and Sanofi have vaccine candidates in the preclinical stages, according to a WHO document.
ADB announces $20-bn virus rescue package
The fund represents the tripling of a package announced just a month ago, which ADB decided to boost as the scale of the contagion’s impact has mushroomed. Nearly simultaneous shutdowns across the global economy, with workers ordered to hunker down at home against the virus, have set the stage for a deep recession. (AFP | PTI)